CollPlant Biotechnologies Stock (NASDAQ: CLGN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 12.16K |
Day Range | - - - |
52 Wk Range | 4.10 - 6.99 |
Market Cap | $53.95M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 0.12% |
Days to Cover | 1.27 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CollPlant Biotechnologies (NASDAQ:CLGN) through any online brokerage.
Other companies in CollPlant Biotechnologies’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Connect Biopharma Hldgs (NASDAQ:CNTB), Intensity Therapeutics (NASDAQ:INTS), Eagle Pharmaceuticals (NASDAQ:EGRX) and Barinthus Biotherapeutics (NASDAQ:BRNS).
CollPlant Biotechnologies has a consensus price target of $15.92.
The stock price for CollPlant Biotechnologies (NASDAQ: CLGN) is $4.71 last updated September 23, 2024 at 7:31 PM EDT.
There are no upcoming dividends for CollPlant Biotechnologies.
CollPlant Biotechnologies’s Q3 earnings are confirmed for Wednesday, November 27, 2024.
There is no upcoming split for CollPlant Biotechnologies.
CollPlant Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.